
|Articles|June 3, 2019
Novel compound shows promise for dry eye in proof-of-concept study
Author(s)Julianne Mobilian
Topical drug for the treatment of dry eye disease sees potential
Advertisement
RELATED:
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Bayer acquires Perfuse Therapeutics, partners with Iambic to expand ophthalmology and AI capabilities
2
Meta's AI glasses for veterans: Canto-Sims, OD on closing the access gap
3
Obstructive sleep apnea and glaucoma: What a 12.5-million-patient data set reveals
4
Memento Medicines launches with $93 million Series A to advance Tie2-activating bispecific for retinal disease
5


























